Disposition of [14C]avitriptan in rats and humans

Drug Metabolism and Disposition

Volumn 25, Issue 7, 1997, Pages 881-888

  Marathe, P H ^a   Greene, D S ^b   Barbhaiya, R H ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AVITRIPTAN; CARBON 14; INDOLE DERIVATIVE; SEROTONIN AGONIST; SULFONAMIDE; TRYPTAMINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; KIDNEY CLEARANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; ANIMAL; AREA UNDER THE CURVE; AUTORADIOGRAPHY; BIOAVAILABILITY; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FECES; HALF LIFE TIME; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RAT STRAIN; SPRAGUE DAWLEY RAT; URINE;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; AUTORADIOGRAPHY; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FECES; HALF-LIFE; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS; SULFONAMIDES; TISSUE DISTRIBUTION; TRYPTAMINES;

EID: 0030610841     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. R. A. Myers, N. S. Sarbin, M. A. Kapin, and F. D. Yocca: Modulation of feline cephalic arterio-venous shunting and systemic hemodynamics following administration of BMS-180048 and sumatriptan. FASEB J. Abstr. 9, A23 (1995).
2. F. D. Yocca, J. A. Gylys, J. Buchanan, and R. A. Myers: Effect of BMS-180048 on carotid arterial blood flow and arteriovenous blood oxygen content in the anesthetized dog. FASEB J. Abstr. 9, A23 (1995).
3. H. L. Wiener, G. P. Thalody, and F. D. Yocca: Kinetic characterization of the responses to BMS-180048, a novel antimigraine agent in cerebral blood vessels. FASEB J. Abstr. 9, A347, (1995).
4. N. S. Sarbin, J. A. Gylys, L. G. Iben, C. D. Mahle, D. G. Izzarelli, E. M. Parker, J. W. Noonan, A. D. Williams, D. W. Smith, E. Hamel, and F. D. Yocca: The receptor binding and vascular in vitro pharmacological profile of BMS-180048. FASEB J. Abstr. 9, A347 (1995).
5. P. H. Marathe, K. D. Larkin, G. F. Duncan, D. S. Greene, and R. H. Barbhaiya: Determination of a novel indolylpiperazine anti-migraine agent in rat, monkey, mouse and rabbit plasma by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 678, 269-277 (1996).
6. M. Gibaldi and D. Perrier: "Pharmacokinetics," 2nd ed. Marcel Dekker, New York, 1982.
7. W. S. Hillis and P. D. MacIntyre: Sumatriptan and chest pain. Lancet 341, 1564-1565, (1993).
8. J. P. Ottervanger, H. J. A. Paalman, G. L. Boxma, and B. H. Stricker: Transmural myocardial infarction with sumatriptan. Lancet 341, 861 (1993).
9. C. M. Dixon, D. A. Saynor, P. D. Andrew, J. Oxford, A. Bradbury, and M. H. Tarbit: Disposition of sumatriptan in laboratory animals and humans. Drug Metab. Dispos. 21, 761-769 (1993).